Tirzepatide

5mg x 10 vials

$310.00 AUD

We provide a streamlined, professional logistics experience to ensure your research materials arrive securely and efficiently.

Premium Freight Line: We utilize a dedicated, specialized freight channel for all shipments. This service includes full management of import documentation and duties, ensuring a seamless delivery process with no additional taxes or customs issues for the researcher.
Estimated Timeline: Delivery typically takes 7–15 business days.
Tracking Updates: Your shipment undergoes a multi-stage dispatch process to ensure safety and compliance. Please allow 3–7 days for your tracking number to be generated and updated in the system.
Carrier Partners: Final delivery is completed by FedEx or UPS.

Product Overview

Tirzepatide is a pioneering dual-agonist peptide that acts on both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This "twincretin" mechanism allows for a synergistic approach to metabolic research. In laboratory models, Tirzepatide is studied for its multi-faceted effects, including:

GLP-1 Receptor Agonism: Investigated for its role in enhancing insulin secretion and slowing gastric emptying.
GIP Receptor Agonism: Researched for its ability to augment insulin response and potentially modulate fat metabolism and energy balance.
Metabolic Homeostasis: Studied for its significant impact on blood glucose regulation and adipose tissue reduction in research subjects.

This dual-action profile makes Tirzepatide a primary subject for researchers exploring advanced treatments for metabolic dysfunction and obesity-related physiological pathways.

Laboratory Research Warning

This product is strictly for laboratory research purposes only. This compound is not for human use, veterinary use, or therapeutic consumption. It has not been evaluated by the FDA. By purchasing, the buyer acknowledges that this is a research chemical intended for use by qualified professionals in a controlled environment.